• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受结直肠癌根治性切除患者的肿瘤增殖活性、全身炎症反应与生存之间的关系。

The relationship between tumour proliferative activity, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer.

作者信息

Canna K, Hilmy M, McMillan D C, Smith G W, McKee R F, McArdle C S, McNicol A-M

机构信息

University Department of Surgery, Royal Infirmary, Glasgow, UK.

出版信息

Colorectal Dis. 2008 Sep;10(7):663-7. doi: 10.1111/j.1463-1318.2007.01416.x. Epub 2007 Nov 12.

DOI:10.1111/j.1463-1318.2007.01416.x
PMID:18005189
Abstract

BACKGROUND

The aim of the present study was to examine the relationship between Ki-67, C-reactive protein and cancer-specific survival in patients undergoing resection for colorectal cancer.

METHOD

One hundred and forty-seven patients undergoing potentially curative resection for colorectal cancer had preoperative C-reactive protein concentrations and tumour Ki-67 labelling index measured.

RESULTS

On univariate analysis, age (P < 0.001), Dukes stage (P < 0.001), C-reactive protein (P < 0.001) and expression of Ki-67 (< 0.01) were associated with poorer cancer-specific survival. Ki-67 labelling index and C-reactive protein were correlated (r(s) = 0.172, P = 0.037). On multivariate analysis, age (HR 1.96, 95% CI 1.26-3.04, P = 0.003), Dukes stage (HR 4.38, 95% CI 2.11-9.09, P < 0.001) and C-reactive protein (HR 4.09, 95% CI 2.04-8.24, P < 0.001) retained significance.

CONCLUSION

Increased tumour proliferation is associated with a systemic inflammatory response and poor cancer-specific survival in patients undergoing potentially curative surgery for colorectal cancer.

摘要

背景

本研究旨在探讨接受结直肠癌切除术患者的Ki-67、C反应蛋白与癌症特异性生存率之间的关系。

方法

对147例接受结直肠癌根治性切除术的患者术前测量C反应蛋白浓度和肿瘤Ki-67标记指数。

结果

单因素分析显示,年龄(P < 0.001)、Dukes分期(P < 0.001)、C反应蛋白(P < 0.001)和Ki-67表达(P < 0.01)与较差的癌症特异性生存率相关。Ki-67标记指数与C反应蛋白相关(r(s)=0.172,P = 0.037)。多因素分析显示,年龄(HR 1.96,95%CI 1.26 - 3.04,P = 0.003)、Dukes分期(HR 4.38,95%CI 2.11 - 9.09,P < 0.001)和C反应蛋白(HR 4.09,95%CI 2.04 - 8.24,P < 0.001)仍具有显著性。

结论

在接受结直肠癌根治性手术的患者中,肿瘤增殖增加与全身炎症反应及较差的癌症特异性生存率相关。

相似文献

1
The relationship between tumour proliferative activity, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer.接受结直肠癌根治性切除患者的肿瘤增殖活性、全身炎症反应与生存之间的关系。
Colorectal Dis. 2008 Sep;10(7):663-7. doi: 10.1111/j.1463-1318.2007.01416.x. Epub 2007 Nov 12.
2
Systemic inflammatory response predicts survival following curative resection of colorectal cancer.全身炎症反应可预测结肠癌根治性切除术后的生存情况。
Br J Surg. 2003 Feb;90(2):215-9. doi: 10.1002/bjs.4038.
3
Preoperative but not postoperative systemic inflammatory response correlates with survival in colorectal cancer.结直肠癌患者术前而非术后的全身炎症反应与生存率相关。
Br J Surg. 2007 Aug;94(8):1028-32. doi: 10.1002/bjs.5706.
4
Relationship between emergency presentation, systemic inflammatory response, and cancer-specific survival in patients undergoing potentially curative surgery for colon cancer.接受结肠癌潜在根治性手术患者的急诊就诊、全身炎症反应与癌症特异性生存之间的关系。
Am J Surg. 2009 Apr;197(4):544-9. doi: 10.1016/j.amjsurg.2007.12.052. Epub 2008 Jul 9.
5
Evaluation of a cumulative prognostic score based on the systemic inflammatory response in patients undergoing potentially curative surgery for colorectal cancer.基于全身炎症反应的累积预后评分在接受结直肠癌根治性手术患者中的评估。
Br J Cancer. 2004 May 4;90(9):1707-9. doi: 10.1038/sj.bjc.6601757.
6
Acute-phase protein response, survival and tumour recurrence in patients with colorectal cancer.结直肠癌患者的急性期蛋白反应、生存率及肿瘤复发情况
Br J Surg. 2001 Feb;88(2):255-60. doi: 10.1046/j.1365-2168.2001.01669.x.
7
The longitudinal relationship between circulating concentrations of C-reactive protein, interleukin-6 and interleukin-10 in patients undergoing resection for renal cancer.接受肾癌切除术患者循环中C反应蛋白、白细胞介素-6和白细胞介素-10浓度的纵向关系。
Br J Cancer. 2006 Oct 23;95(8):1076-80. doi: 10.1038/sj.bjc.6603387. Epub 2006 Sep 26.
8
Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer.基于炎症的病理和生化标准对接受结直肠癌潜在根治性切除患者的预后价值比较。
Ann Surg. 2009 May;249(5):788-93. doi: 10.1097/SLA.0b013e3181a3e738.
9
The presence of a systemic inflammatory response predicts poorer survival in patients receiving adjuvant 5-FU chemotherapy following potentially curative resection for colorectal cancer.对于接受过结直肠癌根治性切除术后辅助性5-氟尿嘧啶化疗的患者,全身炎症反应的存在预示着较差的生存率。
Br J Cancer. 2006 Jun 19;94(12):1833-6. doi: 10.1038/sj.bjc.6603185. Epub 2006 May 23.
10
Tumor size is associated with the systemic inflammatory response but not survival in patients with primary operable colorectal cancer.肿瘤大小与原发性可手术结直肠癌患者的全身炎症反应相关,但与生存率无关。
J Gastroenterol Hepatol. 2007 Dec;22(12):2288-91. doi: 10.1111/j.1440-1746.2006.04792.x.

引用本文的文献

1
Baseline (modified) Glasgow prognostic score as a predictor of therapeutic response to immune checkpoint inhibitors in solid tumors: A systematic review and meta‑analysis.基线(改良)格拉斯哥预后评分作为实体瘤对免疫检查点抑制剂治疗反应的预测指标:一项系统评价和荟萃分析。
Oncol Lett. 2025 Feb 13;29(4):184. doi: 10.3892/ol.2025.14931. eCollection 2025 Apr.
2
The Glasgow Prognostic Score Predicts Outcomes of Pembrolizumab or Atezolizumab Monotherapy in Patients with Pretreated Non-Small Cell Lung Cancer.格拉斯哥预后评分预测预处理非小细胞肺癌患者接受派姆单抗或阿特珠单抗单药治疗的结局。
Oncology. 2023;101(1):69-76. doi: 10.1159/000526964. Epub 2022 Sep 14.
3
Postoperative survival According to the Glasgow Prognostic Score in Patients with Resected Lung Adenocarcinoma.
根据格拉斯哥预后评分评估的肺腺癌切除患者的术后生存率
Asian Pac J Cancer Prev. 2016 Oct 1;17(10):4677-4680. doi: 10.22034/apjcp.2016.17.10.4677.
4
C-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic Review.C反应蛋白是成人实体瘤预后、肿瘤复发及治疗反应的重要生物标志物:一项系统评价
PLoS One. 2015 Dec 30;10(12):e0143080. doi: 10.1371/journal.pone.0143080. eCollection 2015.
5
Simple and Objective Prediction of Survival in Patients with Lung Cancer: Staging the Host Systemic Inflammatory Response.
Lung Cancer Int. 2014;2014:731925. doi: 10.1155/2014/731925. Epub 2014 Mar 5.
6
Emergency presenting colon cancer is an independent predictor of adverse disease-free survival.急诊就诊的结肠癌是无病生存不良的独立预测因素。
Int Surg. 2015 Jan;100(1):77-86. doi: 10.9738/INTSURG-D-13-00281.1.
7
Clinical outcome, proteome kinetics and angiogenic factors in serum after thermoablation of colorectal liver metastases.结直肠肝转移热消融治疗后的临床结果、蛋白质组动力学和血清中血管生成因子。
BMC Cancer. 2013 May 30;13:266. doi: 10.1186/1471-2407-13-266.
8
Comparison of visual and automated assessment of Ki-67 proliferative activity and their impact on outcome in primary operable invasive ductal breast cancer.原发性可手术浸润性导管乳腺癌中 Ki-67 增殖活性的视觉评估与自动评估及其对预后的影响比较。
Br J Cancer. 2012 Jan 17;106(2):383-8. doi: 10.1038/bjc.2011.569. Epub 2012 Jan 3.
9
Breast cancer patients' clinical outcome measures are associated with Src kinase family member expression.乳腺癌患者的临床结局评估与 Src 激酶家族成员的表达相关。
Br J Cancer. 2010 Sep 7;103(6):899-909. doi: 10.1038/sj.bjc.6605829. Epub 2010 Aug 17.
10
Comparison of tumour-based (Petersen Index) and inflammation-based (Glasgow Prognostic Score) scoring systems in patients undergoing curative resection for colon cancer.接受结肠癌根治性切除术患者中基于肿瘤的(彼得森指数)和基于炎症的(格拉斯哥预后评分)评分系统的比较。
Br J Cancer. 2009 Mar 10;100(5):701-6. doi: 10.1038/sj.bjc.6604926. Epub 2009 Feb 10.